Deutsch English Français

Contact

EP2203189

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2203189

EP2203189 - CONTRAST AGENTS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 24.05.2013 Database last updated on 12.07.2024
Most recent event Tooltip	18.07.2014	Lapse of the patent in a contracting state New state(s): HU	published on 20.08.2014 [2014/34]
Applicant(s)	For all designated states GE Healthcare AS Nycoveien 1-2 P.O. Box 4220 Nydalen 0401 Oslo / NO
	[2010/27]
Inventor(s)	01 / WYNN, Duncan, George GE Healthcare Limited The Grove Centre White Lion Road Amersham, Buckinghamshire HP7 9LL / GB
	02 / NEWINGTON, Ian, Martin GE Healthcare Limited The Grove Centre White Lion Road Amersham, Buckinghamshire HP7 9LL / GB
	03 / PRIEBE, Hanno GE Healthcare AS P.O. Box 4220 Nydalen Nycoveien 1-2 N-0401 Oslo / NO
	[2012/29]
Former [2010/27]	01 / WYNN, Duncan, George GE Healthcare Limited The Grove Centre White Lion Road Amersham, Buckinghamshire HP7 9LL / GB
	02 / NEWINGTON, Ian, Martin GE Healthcare Limited The Grove Centre White Lion Road Amersham, Buckinghamshire HP7 9LL / GB
	03 / PRIEBE, Hanno GE Healthcare AS P.O. Box 4220 Nydalen Nycoveien 1-2 N-0401 Oslo / NO
Representative(s)	Wulff, Marianne Weiby, et al GE Healthcare AS P.O. Box 4220 Nydalen Nycoveien 1-2 0401 Oslo / NO
	[N/P]
Former [2010/27]	Wulff, Marianne Weiby, et al GE Healthcare AS P.O. Box 4220 Nydalen Nycoveien 1-2 0401 Oslo / NO
Application number, filing date	08805206.3	10.10.2008
	[2010/27]
	WO2008EP63584
Priority number, date	NO20070005241	12.10.2007 Original published format: NO 20075241
	[2010/27]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2009047315
	Date:	16.04.2009
	Language:	EN
	[2009/16]
	Type:	A1 Application with search report
	No.:	EP2203189
	Date:	07.07.2010
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 16.04.2009 takes the place of the publication of the European patent application.
	[2010/27]
	Type:	B1 Patent specification
	No.:	EP2203189
	Date:	18.07.2012
	Language:	EN
	[2012/29]
Search report(s)	International search report - published on:	EP	16.04.2009
Classification	IPC:	A61K49/04, C07C237/46	[2010/27]
	CPC:	A61K49/0438 (EP,US); C07C237/46 (EP,US)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/27]
Title	German:	KONTRASTMITTEL	[2010/27]
	English:	CONTRAST AGENTS	[2010/27]
	French:	PRODUITS DE CONTRASTE	[2010/27]
Entry into regional phase	12.04.2010	National basic fee paid
	12.04.2010	Designation fee(s) paid
	12.04.2010	Examination fee paid
Examination procedure	12.04.2010	Amendment by applicant (claims and/or description)
	12.04.2010	Examination requested [2010/27]
	11.10.2010	Despatch of a communication from the examining division (Time limit: M04)
	16.02.2011	Reply to a communication from the examining division
	13.01.2012	Despatch of a communication from the examining division (Time limit: M01)
	26.01.2012	Reply to a communication from the examining division
	21.03.2012	Communication of intention to grant the patent
	01.06.2012	Fee for grant paid
	01.06.2012	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 11.10.2010
Opposition(s)	19.04.2013	No opposition filed within time limit [2013/26]
Fees paid	Renewal fee
	25.10.2010	Renewal fee patent year 03
	25.10.2011	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	10.10.2008
	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	CZ	18.07.2012
	DK	18.07.2012
	EE	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	MT	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	RO	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	SK	18.07.2012
	TR	18.07.2012
	IE	10.10.2012
	LU	10.10.2012
	BG	18.10.2012
	NO	18.10.2012
	GR	19.10.2012
	CH	31.10.2012
	LI	31.10.2012
	MC	31.10.2012
	IS	18.11.2012
	PT	19.11.2012
	[2014/34]
Former [2014/27]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	CZ	18.07.2012
	DK	18.07.2012
	EE	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	MT	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	RO	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	SK	18.07.2012
	TR	18.07.2012
	IE	10.10.2012
	LU	10.10.2012
	BG	18.10.2012
	NO	18.10.2012
	GR	19.10.2012
	CH	31.10.2012
	LI	31.10.2012
	MC	31.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2014/21]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	CZ	18.07.2012
	DK	18.07.2012
	EE	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	MT	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	RO	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	SK	18.07.2012
	TR	18.07.2012
	IE	10.10.2012
	BG	18.10.2012
	NO	18.10.2012
	GR	19.10.2012
	CH	31.10.2012
	LI	31.10.2012
	MC	31.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/51]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	CZ	18.07.2012
	DK	18.07.2012
	EE	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	MT	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	RO	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	SK	18.07.2012
	IE	10.10.2012
	BG	18.10.2012
	NO	18.10.2012
	GR	19.10.2012
	CH	31.10.2012
	LI	31.10.2012
	MC	31.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/34]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	CZ	18.07.2012
	DK	18.07.2012
	EE	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	RO	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	SK	18.07.2012
	IE	10.10.2012
	BG	18.10.2012
	NO	18.10.2012
	GR	19.10.2012
	CH	31.10.2012
	LI	31.10.2012
	MC	31.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/33]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	CZ	18.07.2012
	DK	18.07.2012
	EE	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	RO	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	SK	18.07.2012
	IE	10.10.2012
	NO	18.10.2012
	GR	19.10.2012
	CH	31.10.2012
	LI	31.10.2012
	MC	31.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/24]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	CZ	18.07.2012
	DK	18.07.2012
	EE	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	RO	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	SK	18.07.2012
	NO	18.10.2012
	GR	19.10.2012
	MC	31.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/23]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	CZ	18.07.2012
	DK	18.07.2012
	EE	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	RO	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	SK	18.07.2012
	NO	18.10.2012
	GR	19.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/22]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	CZ	18.07.2012
	DK	18.07.2012
	EE	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	NO	18.10.2012
	GR	19.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/21]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	DK	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	NO	18.10.2012
	GR	19.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/15]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	NL	18.07.2012
	PL	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	NO	18.10.2012
	GR	19.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/13]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	PL	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	NO	18.10.2012
	GR	19.10.2012
	IS	18.11.2012
	PT	19.11.2012
Former [2013/12]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	PL	18.07.2012
	SE	18.07.2012
	SI	18.07.2012
	NO	18.10.2012
	GR	19.10.2012
	IS	18.11.2012
Former [2013/11]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	LV	18.07.2012
	PL	18.07.2012
	SI	18.07.2012
	NO	18.10.2012
	GR	19.10.2012
	IS	18.11.2012
Former [2013/10]	AT	18.07.2012
	BE	18.07.2012
	CY	18.07.2012
	FI	18.07.2012
	HR	18.07.2012
	LT	18.07.2012
	NO	18.10.2012
	IS	18.11.2012
Former [2013/09]	AT	18.07.2012
	BE	18.07.2012
	FI	18.07.2012
	LT	18.07.2012
	NO	18.10.2012
Former [2013/08]	AT	18.07.2012
	BE	18.07.2012
	LT	18.07.2012
	NO	18.10.2012
Former [2013/07]	AT	18.07.2012
Cited in	International search	[DY]WO9208691 (DIBRA SPA [IT], et al) [DY] 1-17 * page 1, line 2 - line 6 * * page 2, line 1 * * page 4, line 12 - line 13 * * page 5, line 15 - line 20 * * page 14, line 3 - line 25 * * formula (I) *;
		[Y]WO2007094683 (GE HEALTHCARE AS [NO], et al) [Y] 1-17 * page 6, line 2 - page 7, line 5 *
	by applicant	EP0108638
		WO9001194
		WO9113636
		EP1186305
		EP0686046
		EP0049745
		EP0023992
		WO03080554
		WO0026179
		WO9700240
		WO9208691
		US3804892
		US4239747
		US3763226
		US3763227
		US3678152
		- ASPELIN, P ET AL., THE NEW ENGLAND JOURNAL OF MEDICINE, (2003), vol. 348, pages 491 - 499

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p